IP Library › Granted Patent US 11,474,114
Granted Patent B2
US 11,474,114 · App. 17/077,399 · Granted Oct 18, 2022

Artificial blood for bloodstain pattern analysis

Inventors: Sang Yoon Lee (Wonju-si, KR); Young Il Seo (Wonju-si, KR); Dong A Lim (Daejeon, KR); Kyung Mi Kim (Namyangju-si, KR); Eun Ah Joo (Yongin-si, KR); Je Hyun Lee (Wonju-si, KR); Ki Hwan Kim (Busan, KR); Jin Pyo Kim (Daejeon, KR); Jae Mo Goh (Wonju-si, KR); Nam Kyu Park (Bucheon-si, KR); Se Hyun Shin (Seoul, KR)
Assignee: REPUBLIC OF KOREA (NATIONAL FORENSIC SERVICE DIRECTOR MINISTRY OF THE INTERIOR AND SAFETY)
G01N33/721G01N33/80G01N33/49G01N33/96Y10T436/10Y10T436/106664
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,474,114
App. No.
17/077,399
Granted
Oct 18, 2022
Kind
B2
Abstract

Artificial blood for a bloodstain pattern analysis includes water, an amino acid solution, bovine serum albumin, hemoglobin from bovine blood, potassium ferricyanide, sodium hyaluronate, sodium chloride, and tar color.

Claims (12)

1. Artificial blood for a bloodstain pattern analysis comprising:

water, an amino acid solution, bovine serum albumin, hemoglobin from bovine blood, potassium ferricyanide, sodium hyaluronate, sodium chloride, and tar color.

2. The artificial blood for the bloodstain pattern analysis of claim 1 , wherein the amino acid solution comprises L-serine, glycine, DL-alanine, L-lysine, L-leucine, L-threonine, L-asparagin anhydrous, L-histidine, L-valine, sodium chloride, magnesium chloride hexahydrate, calcium chloride anhydrous, and zinc chloride.

3. The artificial blood for the bloodstain pattern analysis of claim 2 , comprising:

4.5% to 5.5% by weight of L-serine, 2.5% to 3.5% by weight of glycine, 1.0% to 2.0% by weight of DL-alanine, 1.5% to 2.5% by weight of L-lysine, 0.1% to 1.0% by weight of L-leucine, 0.5% to 1.0% by weight of L-threonine, 0.5% to 1.0% by weight of L-anhydrous asparagine, 0.5% to 1.0% by weight of L-histidine, 0.1% to 0.8% by weight of L-valine, 30% to 40% by weight of sodium chloride, 0.0001% to 0.0005% by weight of magnesium chloride hexahydrate, 0.0001% to 0.0015% by weight of calcium chloride anhydrous, and 0.0001% to 0.0005% by weight of zinc chloride with respect to 100% by weight of the artificial blood for the bloodstain pattern analysis.

4. The artificial blood for the bloodstain pattern analysis of claim 1 , comprising:

25% to 30% by weight of water, 40% to 50% by weight of amino acid solution, 0.5% to 2% by weight of bovine serum albumin, 0.01% to 0.2% by weight of hemoglobin from bovine blood, 1.5% to 3% by weight of potassium ferricyanide, 20% to 25% by weight of sodium hyaluronate, 0.5% to 1.5% by weight of sodium chloride, and 0.6% to 2% by weight of tar color with respect to 100% by weight of the artificial blood for the bloodstain pattern analysis.

5. The artificial blood for the bloodstain pattern analysis of claim 1 , further comprising:

phenoxyethanol acting as a preservative.

6. The artificial blood for the bloodstain pattern analysis of claim 5 , comprising:

0.1% to 0.7% by weight of phenoxyethanol with respect to 100% by weight of artificial blood for a blood pattern analysis.

7. The artificial blood for the bloodstain pattern analysis of claim 1 , wherein the tar color comprises food tar color Red No. 504 (R #504) and food tar color Violet No. 401 (V #401).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2020
From: LEE, SANG YOON; SEO, YOUNG IL; LIM, DONG A; KIM, KYUNG MI; JOO, EUN AH; LEE, JE HYUN; KIM, KI HWAN; KIM, JIN PYO; GOH, JAE MO; PARK, NAM KYU; SHIN, SE HYUN
To: REPUBLIC OF KOREA (NATIONAL FORENSIC SERVICE DIRECTOR MINISTRY OF THE INTERIOR AND SAFETY)
Reel/Frame 054142/0046 →
Priority Claims (1)
KR 10-2020-0075161 · Jun 19, 2020 · national
Continuity (1)
Related Publication 20210396770A1 · Dec 23, 2021